Synagis

(palivizumab)

Skip to: what to expect sectionSkip to: side effects sectionSkip to: risks and warnings sectionSkip to: common concerns from users and pharmacists

Stops children from getting Respiratory Syncytial Virus.

Skip Upsides & Downsides section. Skip to side effects section.

Our bottom line

Synagis (palivizumab) is the only medicine that prevents Respiratory Syncytial Virus infection in high risk children.

Quick facts about Synagis
  • Drug class: Infection
  • Rx status: Prescription only
  • Generic status: No lower cost generic available
Prices and discounts
Lowest price for 0.5 0.5ml of 50mg/0.5ml vials
Determining your location...
$1535.26

Upsides

  • Effective in prevention of serious lung disease caused by RSV in patients at risk for severe RSV infection.
  • Only a monthly injection for 5 months is required yearly until the child is greater than 2 years old.
Tried Synagis? Write a review!
Worth itNot sureNot worth it

Downsides

  • Synagis (palivizumab) is only used for prevention and not treatment of RSV infections.
  • Safety and effectiveness of Synagis (palivizumab) has only been shown in children up to 2 years of age.
  • Synagis (palivizumab) is a monthly injection in the thigh for up to 5 shots during RSV season.
  • Can cause rash and fever.
  • Can rarely cause serious allergic reactions (difficulty breathing, swelling of lips and face, rash, itching, low blood pressure) and lower platelet count.
Prices and discounts
Lowest price for 0.5 0.5ml of 50mg/0.5ml vials
Determining your location...
$1535.26
How it works

Synagis (palivizumab) is not a vaccine but an injection of antibodies that prevents infection with Respiratory Syncytial Virus.

Quick facts about Synagis
  • Drug class: Infection
  • Rx status: Prescription only
  • Generic status: No lower cost generic available

Used for

  • Prevention of respiratory syncytial virus (RSV) infection

Dosage forms

  • Injection
Tried Synagis? Write a review!
Worth itNot sureNot worth it

What to expect when you take Synagis (palivizumab) for Prevention of RSV infection

Skip what to expect section. Skip to side effects section.
Skip side effects section. Skip to risks and warnings section.

Side effect rates for Synagis (palivizumab)

2782 From clinical trials of Synagis / Prevention of RSV infection
  • Rash
  • Fever

Risks and Warnings for Synagis (palivizumab)

Skip risks section. Skip to common concerns section.
  • Rarely, children getting Synagis (palivizumab) can have a serious allergic reaction including hives, itching, sudden drop in blood pressure, trouble breathing, and swelling of the face and throat. Synagis (palivizumab) is usually given in a clinic or the hospital so nurses and doctors will be able to respond.